Log In
BCIQ
Print this Print this
 

Exemptia (Biosimilar adalimumab)

  Manage Alerts
Collapse Summary General Information
Company Zydus Cadila Group
DescriptionBiosimilar of adalimumab, an anti tumor necorisis factor (TNF) alpha mAb
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today